Attached files
| file | filename |
|---|---|
| S-1 - S-1 - ELITE PHARMACEUTICALS INC /NV/ | v300926_s1.htm |
| EX-21.1 - EXHIBIT 21.1 - ELITE PHARMACEUTICALS INC /NV/ | v300926_ex21.htm |
| EX-5.1 - EXHIBIT 5.1 - ELITE PHARMACEUTICALS INC /NV/ | v300926_ex5-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ELITE PHARMACEUTICALS INC /NV/ | Financial_Report.xls |
Exhibit “23.1”
ELITE PHARMACEUTICALS, INC. AND SUBSIDIARIES
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated June 29, 2011, which report expresses an unqualified opinion and includes an explanatory paragraph referring to uncertainty about the Company’s ability to continue as a going concern, relating to the consolidated financial statements of Elite Pharmaceuticals, Inc. and Subsidiaries contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts.”
/S/ Demetrius & Company, LLC.
Wayne, New Jersey
March 1, 2012